Pacific Biosciences Of California PACB
NASDAQ PACB
$2.24 -0.13 (-5.49%)
At close: Nov 10, 2026 · 4:00 PM EST

Pacific Biosciences Of California (PACB) Return on Equity [ROE] (2010 - 2026)

Updated

Pacific Biosciences Of California's Return on Equity [ROE] was -3333.14% in Q1 2026, down 3113.25 percentage points from -219.90% a year earlier and down 696.13 percentage points from the prior quarter.

Analysis

Pacific Biosciences Of California (PACB) Return on Equity [ROE] (2010 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Pacific Biosciences Of California came in at -213.45%, down 162.15 percentage points from FY2024.

  • Return on Equity [ROE] has now declined for five consecutive years, with a five-year change of -228.51 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was -51.30% in FY2024 (-2.78 pp), -48.53% in FY2023 (-2.10 pp), -46.42% in FY2022 (-14.25 pp) and -32.18% in FY2021 (-47.24 pp).
  • The Q1 2026 figure marks the lowest quarterly Return on Equity [ROE] in data going back to Q3 2011.
  • Compared with a year earlier, Return on Equity [ROE] has declined for eight straight quarters, with an average year-over-year change of -939.03 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q2 2021 (a gain of 194.64 percentage points); the worst was Q1 2026 (a drop of 3113.25 percentage points).
  • Per Business Quant data, PACB's Return on Equity [ROE] in the three quarters before Q1 2026 was -2637.01% (Q4 2025), -1032.26% (Q3 2025) and -687.48% (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 13.20%
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 9.09%
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 8.15%
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 17.28%
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 17.46%
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn -4.01%
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 13.69%
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 9.36%
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 4.56%
10 Pacific Biosciences Of California 699.41 Mn -292.35 Mn 13.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,346.83%
Dec 31, 2025 -2,636.84%
Sep 30, 2025 -1,031.86%
Jun 30, 2025 -687.42%
Mar 31, 2025 -219.84%
Dec 31, 2024 -64.53%
Sep 30, 2024 46,769.48%
Jun 30, 2024 27,189.88%
Mar 31, 2024 12,559.10%
Dec 31, 2023 11,574.66%
Sep 30, 2023 -19,461.05%
Jun 30, 2023 -10,619.89%
Mar 31, 2023 -50.77%
Dec 31, 2022 -53.46%
Sep 30, 2022 -46.69%
Jun 30, 2022 -29.81%
Mar 31, 2022 -23.53%
Dec 31, 2021 -22.36%
Sep 30, 2021 5,353.06%
Jun 30, 2021 10,904.29%
API Access

Pacific Biosciences Of California Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PACB&period=max&api_key=YOUR_API_KEY